GRIA2
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene. [provided by RefSeq, Jul 2008]
Full Name
Glutamate ionotropic receptor AMPA type subunit 2
Function
Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system (PubMed:31300657).
It plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate. Through complex formation with NSG1, GRIP1 and STX12 controls the intracellular fate of AMPAR and the endosomal sorting of the GRIA2 subunit toward recycling and membrane targeting (By similarity).
It plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate. Through complex formation with NSG1, GRIP1 and STX12 controls the intracellular fate of AMPAR and the endosomal sorting of the GRIA2 subunit toward recycling and membrane targeting (By similarity).
Biological Process
Chemical synaptic transmission Source: ProtInc
Ionotropic glutamate receptor signaling pathway Source: UniProtKB
Signal transduction Source: ProtInc
Synaptic transmission, glutamatergic Source: ARUK-UCL
Ionotropic glutamate receptor signaling pathway Source: UniProtKB
Signal transduction Source: ProtInc
Synaptic transmission, glutamatergic Source: ARUK-UCL
Cellular Location
Cell membrane; Postsynaptic cell membrane; Postsynaptic density membrane; Endoplasmic reticulum membrane. Interaction with CACNG2, CNIH2 and CNIH3 promotes cell surface expression (By similarity). Displays a somatodendritic localization and is excluded from axons in neurons (By similarity).
Involvement in disease
Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB):
A neurodevelopmental disorder characterized by global developmental delay, impaired intellectual development, poor or absent speech, and behavioral abnormalities, such as autism spectrum disorder, repetitive behaviors, and hyperactivity. Some patients develop seizures and manifest developmental regression.
A neurodevelopmental disorder characterized by global developmental delay, impaired intellectual development, poor or absent speech, and behavioral abnormalities, such as autism spectrum disorder, repetitive behaviors, and hyperactivity. Some patients develop seizures and manifest developmental regression.
Topology
Extracellular: 25-543
Helical: 544-564
Cytoplasmic: 565-591
Helical: 592-607
Extracellular: 608-610
Helical: 611-616
Cytoplasmic: 617-637
Helical: 638-812
Extracellular: 813-833
Helical: 834-883
Helical: 544-564
Cytoplasmic: 565-591
Helical: 592-607
Extracellular: 608-610
Helical: 611-616
Cytoplasmic: 617-637
Helical: 638-812
Extracellular: 813-833
Helical: 834-883
PTM
Palmitoylated. Depalmitoylated upon glutamate stimulation. Cys-610 palmitoylation leads to Golgi retention and decreased cell surface expression. In contrast, Cys-836 palmitoylation does not affect cell surface expression but regulates stimulation-dependent endocytosis (By similarity).
Phosphorylation at Tyr-876 is required forc interaction with IQSEC1 and ARF6 activation.
Phosphorylation at Tyr-876 is required forc interaction with IQSEC1 and ARF6 activation.
View more
Anti-GRIA2 antibodies
+ Filters
Loading...
Target: GRIA2
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBNH-057
Application*: E
Target: GRIA2
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 4C7
Application*: E
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBT3944
Application*: F
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBT4536
Application*: IH, F
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT2305
Application*: WB, F
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Mouse, Rat
Clone: 6C4
Application*: E, IH, WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-I1268
Application*: WB, F
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBFYH-3477
Application*: E, F, WB
Target: GRIA2
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human, Mouse
Clone: CBLG1-1736
Application*: WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Rat
Clone: CBLG1-1735
Application*: E, IC, IH, R, WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBLG1-1734
Application*: E, P, WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG1
Specificity: Rat, Human, Mouse
Clone: S21-32
Application*: WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBLG1-232
Application*: E, IH, WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Rat
Clone: CBLG1-230
Application*: E, IC, IH, R, WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBLG1-229
Application*: E, IH, WB
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: CBLG1-228
Application*: F
Target: GRIA2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Rat
Clone: 3A11
Application*: E, IC, IF, IH, IP, WB
More Infomation
Hot products 
-
Mouse Anti-AZGP1 Recombinant Antibody (CBWJZ-007) (CBMAB-Z0012-WJ)
-
Mouse Anti-ACVR1C Recombinant Antibody (V2-179685) (CBMAB-A1041-YC)
-
Mouse Anti-ABL2 Recombinant Antibody (V2-179121) (CBMAB-A0364-YC)
-
Mouse Anti-AKT1/AKT2/AKT3 (Phosphorylated T308, T309, T305) Recombinant Antibody (V2-443454) (PTM-CBMAB-0030YC)
-
Mouse Anti-AMIGO2 Recombinant Antibody (CBYY-C0756) (CBMAB-C2192-YY)
-
Mouse Anti-ABIN2 Recombinant Antibody (V2-179106) (CBMAB-A0349-YC)
-
Mouse Anti-DLL4 Recombinant Antibody (D1090) (CBMAB-D1090-YC)
-
Rabbit Anti-BRCA2 Recombinant Antibody (D9S6V) (CBMAB-CP0017-LY)
-
Mouse Anti-CD1C Recombinant Antibody (L161) (CBMAB-C2173-CQ)
-
Mouse Anti-CFL1 (Phospho-Ser3) Recombinant Antibody (CBFYC-1770) (CBMAB-C1832-FY)
-
Mouse Anti-C4B Recombinant Antibody (CBYY-C2996) (CBMAB-C4439-YY)
-
Mouse Anti-BAX Recombinant Antibody (CBYY-0216) (CBMAB-0217-YY)
-
Mouse Anti-C5AR1 Recombinant Antibody (R63) (CBMAB-C9553-LY)
-
Mouse Anti-CSPG4 Recombinant Antibody (CBFYM-1050) (CBMAB-M1203-FY)
-
Mouse Anti-AAV9 Recombinant Antibody (V2-634029) (CBMAB-AP023LY)
-
Mouse Anti-ATP1B1 Recombinant Antibody (E4) (CBMAB-0463-LY)
-
Mouse Anti-EGR1 Recombinant Antibody (CBWJZ-100) (CBMAB-Z0289-WJ)
-
Mouse Anti-ARG1 Recombinant Antibody (CBYCL-103) (CBMAB-L0004-YC)
-
Mouse Anti-F11R Recombinant Antibody (402) (CBMAB-0026-WJ)
-
Rat Anti-EPO Recombinant Antibody (16) (CBMAB-E1578-FY)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry




